SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-138884
Filing Date
2023-05-09
Accepted
2023-05-09 07:16:53
Documents
12
Period of Report
2023-05-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d421868d8k.htm   iXBRL 8-K 23907
  Complete submission text file 0001193125-23-138884.txt   149422

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hlvx-20230508.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hlvx-20230508_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hlvx-20230508_pre.xml EX-101.PRE 11701
6 EXTRACTED XBRL INSTANCE DOCUMENT d421868d8k_htm.xml XML 3463
Mailing Address 75 STATE ST. SUITE 100 BOSTON MA 02109
Business Address 75 STATE ST. SUITE 100 BOSTON MA 02109 (617) 213-5054
HilleVax, Inc. (Filer) CIK: 0001888012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41365 | Film No.: 23899957
SIC: 2836 Biological Products, (No Diagnostic Substances)